Local antithrombotic therapy using a novel porous balloon catheter

Japanese Heart Journal

Volumn 41, Issue 1, 2000, Pages 87-95

  Tomaru, Takanobu ^a   Kobayakawa, Naoshi ^a   Onitake, Asako ^a   Nakamura, Fumitaka ^b   Morita, Toshihiro ^b   Uchida, Yasumi ^c  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Antithrombin; Local delivery; Porous balloon catheter; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; DRUG INFUSION; DRUG MEGADOSE; ILIAC ARTERY; NONHUMAN; PRIORITY JOURNAL; THROMBUS;

EID: 0034029773     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.41.87     Document Type: Article

References (15)

1. Gold HK, Coller BS, Yasuda T, et al. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue type plasminogen activator and monoclonal antiplatelet GP IIb/IIa antibody in a canine preparation. Circulation 1988; 77: 670-7.
2. Mirshahi M, Soria J, Soria C, et al. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. Blood 1989; 74: 1025-30.
3. Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Circulation 1989; 79: 657-65.
4. Heras M, Chesebro JH, Webster MWI, et al. Hirudin, heparin and placebo during deep arterial injury in the pig. Circulation 1990;82: 1476-84.
5. Tomaru T, Nakamura F, Miwa A, et al. Antithrombin and thrombolytic effects of a new antithrombin agent: Angioscopic and angiographie comparison with heparin or batroxobin. J Interven Cardiol 1994; 7: 409-20.
6. Dormandy JA, Reid HC. Controlled defibrination in the treatment of peripheral vascular disease. Angiology 1978; 29: 80-6.
7. Wolinsky H, Thung S. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 1990; 15: 475-81.
8. Camenzind E, Kint PP, Di Mario C, et al. Intracoronary heparin delivery in humans: acute feasibility and long-term results. Circulation 1995; 92: 2463-72.
9. Nunes GL, Hanson SR, King III SB, Sahatjian RA, Scott NA. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis, J Am Coll Cardiol 1994; 23: 1578-83.
10. Araki H, Muramoto J, Nishi K, Jougasaki M, Inoue M. Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity. Circ Res 1992; 71: 577-84.
11. Tomaru T, Nakamura F, Fujimori Y, et al. Local treatment with antithrombotic drug can prevent thrombus formation: angioscopic and angiographie study. J Am College Cardiol 1995; 26: 1325-32.
12. Mitchel JF, Fram DB, Palme DF II, et al. Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system: in vitro, in vivo, and clinical studies. Circulation 1995; 3: 785-793.
13. Meyer BJ, Fernandez-Oritz A, Mailhac A, et al. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 1994; 90: 2474-80.
14. Sherman CT, Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913-21.
15. Tomaru T, Uchida Y, Nakamura F, Sonoki H, Tsukamoto M, Sugimoto T. Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study. Am Heart J 1989; 117: 275-81.